Aurinia Pharmaceuticals Inc. (AUPH) stock
AUPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 13/3062% below fair value
$15.73−0.48 (-2.96%)
Close on Nov 13, 2026Market cap $2.11BP/E 6.9Yield –
Aurinia Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
Aurinia Pharmaceuticals's operating margin for the twelve months ending Sep 30, 2026 was 48.6%. For fiscal 2025 it was 37.1%, against -2.0% the year before. The highest annual figure on record is 37.1% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 37.1% | +39.1 |
| FY2024 | Dec 31, 2024 | -2.0% | +50.2 |
| FY2023 | Dec 31, 2023 | -52.2% | +30.9 |
| FY2022 | Dec 31, 2022 | -83.2% | +313.1 |
| FY2021 | Dec 31, 2021 | -396.3% | −188.2 |
| FY2020 | Dec 31, 2020 | -208.1% | +28390.3 |
| FY2019 | Dec 31, 2019 | -28598.4% | −16667.5 |
| FY2018 | Dec 31, 2018 | -11930.9% | −718.4 |
| FY2017 | Dec 31, 2017 | -11212.4% | +3254.0 |
| FY2016 | Dec 31, 2016 | -14466.5% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 42.3% | +1.8 |
| Q2 FY2026 | Jun 30, 2026 | 55.7% | +27.0 |
| Q1 FY2026 | Mar 31, 2026 | 53.3% | +18.3 |
| Q4 FY2025 | Dec 31, 2025 | 43.1% | +45.9 |
| Q3 FY2025 | Sep 30, 2025 | 40.5% | +23.2 |
| Q2 FY2025 | Jun 30, 2025 | 28.7% | +31.3 |
| Q1 FY2025 | Mar 31, 2025 | 35.0% | +61.3 |
| Q4 FY2024 | Dec 31, 2024 | -2.8% | +63.0 |
| Q3 FY2024 | Sep 30, 2024 | 17.3% | +47.2 |
| Q2 FY2024 | Jun 30, 2024 | -2.6% | +36.3 |
| Q1 FY2024 | Mar 31, 2024 | -26.3% | +59.6 |
| Q4 FY2023 | Dec 31, 2023 | -65.8% | +33.0 |
| Q3 FY2023 | Sep 30, 2023 | -29.8% | −12.8 |
| Q2 FY2023 | Jun 30, 2023 | -39.0% | +88.7 |
| Q1 FY2023 | Mar 31, 2023 | -86.0% | +89.2 |
| Q4 FY2022 | Dec 31, 2022 | -98.8% | +40.9 |
| Q3 FY2022 | Sep 30, 2022 | -17.0% | +326.3 |
| Q2 FY2022 | Jun 30, 2022 | -127.7% | +584.3 |
| Q1 FY2022 | Mar 31, 2022 | -175.2% | +5354.7 |
| Q4 FY2021 | Dec 31, 2021 | -139.7% | −123.6 |
| Q3 FY2021 | Sep 30, 2021 | -343.3% | +145570.5 |
| Q2 FY2021 | Jun 30, 2021 | -712.0% | +91919.0 |
| Q1 FY2021 | Mar 31, 2021 | -5529.9% | +84670.1 |
| Q4 FY2020 | Dec 31, 2020 | -16.1% | +120125.3 |
| Q3 FY2020 | Sep 30, 2020 | -145913.8% | −135449.4 |
| Q2 FY2020 | Jun 30, 2020 | -92631.0% | −33517.2 |
| Q1 FY2020 | Mar 31, 2020 | -90200.0% | −40563.3 |
| Q4 FY2019 | Dec 31, 2019 | -120141.4% | – |
| Q3 FY2019 | Sep 30, 2019 | -10464.3% | – |
| Q2 FY2019 | Jun 30, 2019 | -59113.8% | – |
| Q1 FY2019 | Mar 31, 2019 | -49636.7% | – |
See a number that looks wrong?